Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - OPERATING EXPENSES
Operating Expenses RPRX - Royalty Pharma plc
862 M
LAST VALUE
0.21%
2 YEAR CAGR
14.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR